Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Increasing age, female sex, KPS ≤70 associated with increased risk of hospital-associated disability among myeloma patients getting ASCT (Autologous stem cell transplant), which has a 2-fold higher risk of 30-day readmission and 3.7-fold increased mortality.”
Source: Robert Orlowski/X
Authors: Kyle Kidwell, Susan Bal, Kelly Godby, Gayathri Ravi, Luciano J Costa, Sadeep Shrestha, Donna Salzman, Tiffany Hayes, Grant R Williams, Smita Bhatia and Smith Giri.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023